Researchers at three institutions in the U.S. and U.K. receive grants to advance studies of repurposed drugs and novel antibodies in preventing COVID-19 Purchase, N.Y., April 1, 2020: The partners in the COVID-19 Therapeutics Accelerator announced grants of $20 million to three institutions—the University of Washington, University of Oxford, and La Jolla Institute for Immunology—to …
Read More

A Letter to Our Community

March 18, 2020 15:41

To the Mastercard Community– COVID-19 has become part of our new reality. At best, we are faced with the new challenges of social isolation and figuring out how to use digital connections to stay close with our family, friends and colleagues and to help our children continue to learn. At worst, we are battling the …
Read More

COVID-19 Therapeutics Accelerator will coordinate R&D efforts and remove barriers to drug development and scale-up to address the epidemic SEATTLE, March 10, 2020 – The Bill & Melinda Gates Foundation, Wellcome and Mastercard today committed up to $125 million in seed funding to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and …
Read More

$10 Million Challenge Launched to Help Crowdsource Solutions to Social Challenges DAVOS, Switzerland, January 23, 2020 – The Mastercard Center for Inclusive Growth and The Rockefeller Foundation today announced data.org as a platform for partnerships that will continue to build the field of data science for social impact. This is the next chapter of a $50 …
Read More

Much has been written recently about the role of companies in society. At Mastercard, we believe that the ideas of profit and purpose are not mutually exclusive. Instead, the greatest impact can come when companies use their products, technology, know-how and people to deliver solutions that have make a difference in people’s everyday lives, while …
Read More